SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-083172
Filing Date
2020-07-13
Accepted
2020-07-13 18:27:21
Documents
1
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2024764-1_4.html 4  
1 FORM 4 tm2024764-1_4.xml 4 8898
  Complete submission text file 0001104659-20-083172.txt   11189
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Reporting) CIK: 0000014272 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36065 | Film No.: 201025983
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Reporting) CIK: 0000816284 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36065 | Film No.: 201025982
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Issuer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences